SCHEMBL24891788

SCHEMBL24891788

N#Cc1c(Cl)nc(Cl)c2c1CNCC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.46
ALDH1A1 P00352 4/20 0.46
GAA P10253 2/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
KDM4E B2RXH2 2/20 0.44
PNMT P11086 7/20 0.41
NSD2 O96028 1/20 0.41
MAPK1 P28482 1/20 0.41
GLA P06280 2/20 0.41
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24891984 0.82 KDM4E (0.38) HTTALDH1A1GAAHPGDLMNA
SCHEMBL13329206 0.76 KDM4E (0.70) HTTALDH1A1GAAHPGDLMNA
SCHEMBL13329199 0.76 KDM4E (0.65) HTTALDH1A1GAAHPGDLMNA
SCHEMBL24892162 0.75 HTT (0.42) HTTALDH1A1GAAHPGDLMNA
SCHEMBL13329207 0.74 KDM4E (0.68) HTTALDH1A1GAAHPGDLMNA
SCHEMBL28308550 0.71 NSD2 (0.44) HTTALDH1A1GAAHPGDLMNA
Hydrochloric Acid SCHEMBL30182966 0.70 SMN1; SMN2 (0.40) HTTALDH1A1GAAHPGDLMNA
SCHEMBL2826099 0.67 ALDH1A1 (0.48) HTTALDH1A1GAAHPGDLMNA
SCHEMBL13329203 0.67 ALDH1A1 (0.48) HTTALDH1A1GAAHPGDLMNA
SCHEMBL23930712 0.66 HTT (0.50) HTTALDH1A1GAAHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023285583-A1 5,6,7,8-TETRAHYDRO-2,6- AND 2,7-NAPHTHYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF DISEASES RESPONSIVE TO CITRATE TRANSPORTER MODULATION ETERNYGEN UK LTD. (GB) 2023-01-19 WO disclosed